J Liver Cancer.  2024 Mar;24(1):57-61. 10.17998/jlc.2024.03.03.

Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database

• Kim BH
• Yun EH
• Lee JH
• Hong G
• Park JY
• Shim JH
• Kim E
• Kong HJ
• Jung KW
• Lim YS

• KMID: 2553818
• DOI: http://doi.org/10.17998/jlc.2024.03.03

Abstract

Hepatocellular carcinoma (HCC) presents a substantial public health challenge in South Korea as evidenced by 10,565 new cases annually (incidence rate of 30 per 100,000 individuals), in 2020. Cancer registries play a crucial role in gathering data on incidence, disease attributes, etiology, treatment modalities, outcomes, and informing health policies. The effectiveness of a registry depends on the completeness and accuracy of data. Established in 1999 by the Ministry of Health and Welfare, the Korea Central Cancer Registry (KCCR) is a comprehensive, legally mandated, nationwide registry that captures nearly all incidence and survival data for major cancers, including HCC, in Korea. However, detailed information on cancer staging, specific characteristics, and treatments is lacking. To address this gap, the KCCR, in partnership with the Korean Liver Cancer Association (KLCA), has implemented a systematic approach to collect detailed data on HCC since 2010. This involved random sampling of 10-15% of all new HCC cases diagnosed since 2003. The registry process encompassed four stages: random case selection, meticulous data extraction by trained personnel, expert validation, anonymization of personal data, and data dissemination for research purposes. This random sampling strategy mitigates the biases associated with voluntary reporting and aligns with stringent privacy regulations. This innovative approach positions the KCCR and KLCA as foundations for advancing cancer control and shaping health policies in South Korea.

Keyword

Carcinoma, hepatocellular; Registries; Epidemiology; Incidence; Neoplasm staging

Figure

• 

  Figure 1. Key steps in collecting and distributing Korean nationwide HCC registry data. HCC, hepatocellular carcinoma.

Reference

References

1. Kang MJ, Jung KW, Bang SH, Choi SH, Park EH, Yun EH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2020. Cancer Res Treat. 2023; 55:385–399.

2. Edwards D, Bell J. Cancer registries--future development and uses in Britain. J Public Health Med. 2000; 22:216–219.

3. Brewster DH, Coebergh JW, Storm HH. Population-based cancer registries: the invisible key to cancer control. Lancet Oncol. 2005; 6:193–195.

4. Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res Treat. 2022; 54:330–344.

5. Hong S, Won YJ, Lee JJ, Jung KW, Kong HJ, Im JS, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2018. Cancer Res Treat. 2021; 53:301–315.

6. White MC, Babcock F, Hayes NS, Mariotto AB, Wong FL, Kohler BA, et al. The history and use of cancer registry data by public health cancer control programs in the United States. Cancer. 2017; 123 Suppl 24:4969–4976.

7. Wang HJ. Cancer registry for primary liver cancer. Korean J Hepatobiliary Pancreat Surg. 2004; 8:207–216.

8. Ichikawa T, Sano K, Morisaka H. Diagnosis of pathologically early HCC with EOB-MRI: experiences and current consensus. Liver Cancer. 2014; 3:97–107.

9. Kim BH, Lim YS, Kim EY, Kong HJ, Won YJ, Han S, et al. Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus-endemic population. J Gastroenterol Hepatol. 2018; 33:475–483.

10. Yoon JS, Lee HA, Park JY, Kim BH, Lee IJ, Chon YE, et al. Hepatocellular carcinoma in Korea between 2008 and 2011: an analysis of Korean Nationwide Cancer Registry. J Liver Cancer. 2020; 20:41–52.

11. Chon YE, Lee HA, Yoon JS, Park JY, Kim BH, Lee IJ, et al. Hepatocellular carcinoma in Korea between 2012 and 2014: an analysis of data from the Korean Nationwide Cancer Registry. J Liver Cancer. 2020; 20:135–147.

12. Yoon JS, Lee HA, Kim HY, Sinn DH, Lee DH, Hong SK, et al. Hepatocellular carcinoma in Korea: an analysis of the 2015 Korean Nationwide Cancer Registry. J Liver Cancer. 2021; 21:58–68.

13. Andersson TM, Rutherford MJ, Myklebust TÅ, Møller B, Soerjomataram I, Arnold M, et al. Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study. Br J Cancer. 2021; 124:1026–1032.

14. Merriman KW, Broome RG, De Las Pozas G, Landvogt LD, Qi Y, Keating J. Evolution of the cancer registrar in the era of informatics. JCO Clin Cancer Inform. 2021; 5:272–278.